Andrew Left faces federal charges for allegedly manipulating the prices of more than 20 stocks, including Nvidia and Tesla, to net a $16 million profit
A Los Angeles courtroom has commenced trial on a federal securities fraud case involving Andrew Left, the prominent founder of Citron Research.
The ruling could have broad implications for activist short sellers, who make money when stocks decline after critical reports are released.
Unlike short sellers, who often work quietly, activist short sellers publicly speak about a company being overvalued, fraudulent, or failing. They often release well-researched reports to the public and the media.
Left faces federal charges for allegedly manipulating the prices of more than 20 stocks, including Nvidia and Tesla, to net a $16 million profit. Prosecutors claim he used his platform to post market-moving opinions while secretly trading against his public advice.
He gained fame in the 2010s for exposing fraud at Valeant Pharmaceuticals and the Chinese real estate firm, Evergrande.
Left faced indictment in 2024 over claims that he made money from stock volatility driven by his online posts and TV appearances while misrepresenting his positions.
If found guilty, he faces a prison sentence of up to 25 years. Left’s defense centers on First Amendment protections, arguing his reports are protected speech.
The high-stakes trial serves as a landmark test for the SEC’s ability to police activist short sellers.